Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells

Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models.

Guardado en:
Detalles Bibliográficos
Autores principales: Clément Larrue, Nathan Guiraud, Pierre-Luc Mouchel, Marine Dubois, Thomas Farge, Mathilde Gotanègre, Claudie Bosc, Estelle Saland, Marie-Laure Nicolau-Travers, Marie Sabatier, Nizar Serhan, Ambrine Sahal, Emeline Boet, Sarah Mouche, Quentin Heydt, Nesrine Aroua, Lucille Stuani, Tony Kaoma, Linus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann, François Vergez, Jérôme Tamburini, Christian Récher, Jean-Emmanuel Sarry
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b00921
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e5db0cc7b23d4c7f80b655c467b00921
record_format dspace
spelling oai:doaj.org-article:e5db0cc7b23d4c7f80b655c467b009212021-12-02T13:48:51ZAdrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells10.1038/s41467-020-20717-92041-1723https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b009212021-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-20717-9https://doaj.org/toc/2041-1723Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models.Clément LarrueNathan GuiraudPierre-Luc MouchelMarine DuboisThomas FargeMathilde GotanègreClaudie BoscEstelle SalandMarie-Laure Nicolau-TraversMarie SabatierNizar SerhanAmbrine SahalEmeline BoetSarah MoucheQuentin HeydtNesrine ArouaLucille StuaniTony KaomaLinus AngenendtJan-Henrik MikeschChristoph SchliemannFrançois VergezJérôme TamburiniChristian RécherJean-Emmanuel SarryNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Clément Larrue
Nathan Guiraud
Pierre-Luc Mouchel
Marine Dubois
Thomas Farge
Mathilde Gotanègre
Claudie Bosc
Estelle Saland
Marie-Laure Nicolau-Travers
Marie Sabatier
Nizar Serhan
Ambrine Sahal
Emeline Boet
Sarah Mouche
Quentin Heydt
Nesrine Aroua
Lucille Stuani
Tony Kaoma
Linus Angenendt
Jan-Henrik Mikesch
Christoph Schliemann
François Vergez
Jérôme Tamburini
Christian Récher
Jean-Emmanuel Sarry
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
description Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy response in AML preclinical models.
format article
author Clément Larrue
Nathan Guiraud
Pierre-Luc Mouchel
Marine Dubois
Thomas Farge
Mathilde Gotanègre
Claudie Bosc
Estelle Saland
Marie-Laure Nicolau-Travers
Marie Sabatier
Nizar Serhan
Ambrine Sahal
Emeline Boet
Sarah Mouche
Quentin Heydt
Nesrine Aroua
Lucille Stuani
Tony Kaoma
Linus Angenendt
Jan-Henrik Mikesch
Christoph Schliemann
François Vergez
Jérôme Tamburini
Christian Récher
Jean-Emmanuel Sarry
author_facet Clément Larrue
Nathan Guiraud
Pierre-Luc Mouchel
Marine Dubois
Thomas Farge
Mathilde Gotanègre
Claudie Bosc
Estelle Saland
Marie-Laure Nicolau-Travers
Marie Sabatier
Nizar Serhan
Ambrine Sahal
Emeline Boet
Sarah Mouche
Quentin Heydt
Nesrine Aroua
Lucille Stuani
Tony Kaoma
Linus Angenendt
Jan-Henrik Mikesch
Christoph Schliemann
François Vergez
Jérôme Tamburini
Christian Récher
Jean-Emmanuel Sarry
author_sort Clément Larrue
title Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
title_short Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
title_full Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
title_fullStr Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
title_full_unstemmed Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
title_sort adrenomedullin-calcrl axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b00921
work_keys_str_mv AT clementlarrue adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT nathanguiraud adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT pierrelucmouchel adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT marinedubois adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT thomasfarge adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT mathildegotanegre adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT claudiebosc adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT estellesaland adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT marielaurenicolautravers adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT mariesabatier adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT nizarserhan adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT ambrinesahal adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT emelineboet adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT sarahmouche adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT quentinheydt adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT nesrinearoua adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT lucillestuani adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT tonykaoma adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT linusangenendt adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT janhenrikmikesch adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT christophschliemann adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT francoisvergez adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT jerometamburini adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT christianrecher adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
AT jeanemmanuelsarry adrenomedullincalcrlaxiscontrolsrelapseinitiatingdrugtolerantacutemyeloidleukemiacells
_version_ 1718392471652663296